Scarica l'app Stockscreener
0.4559
1.89%
-0.0088
Pre-mercato:
.45
-0.0059
-1.29%
Precedente Chiudi:
$0.4647
Aprire:
$0.4514
Volume 24 ore:
1.50M
Relative Volume:
0.29
Capitalizzazione di mercato:
$72.33M
Reddito:
$3,000
Utile/perdita netta:
$-140.95M
Rapporto P/E:
-0.2229
EPS:
-2.0449
Flusso di cassa netto:
$-90.89M
1 W Prestazione:
-3.66%
1M Prestazione:
-9.17%
6M Prestazione:
-70.96%
1 anno Prestazione:
-60.70%
Intervallo 1D:
$0.4322
$0.4559
Intervallo di 1 settimana:
$0.42
$0.471
Portata 52W:
$0.3772
$3.03
Fractyl Health Inc Stock (GUTS) Company Profile
Nome
Fractyl Health Inc
Settore
Industria
Telefono
781-902-8800
Indirizzo
3 VAN DE GRAAFF DRIVE, BURLINGTON
Compare GUTS vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GUTS
Fractyl Health Inc
|
0.4559 | 72.33M | 3,000 | -140.95M | -90.89M | -2.0449 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Fractyl Health Inc Stock (GUTS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-30 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-15 | Iniziato | H.C. Wainwright | Buy |
| 2025-08-28 | Iniziato | Ladenburg Thalmann | Buy |
| 2024-02-28 | Iniziato | Evercore ISI | Outperform |
| 2024-02-27 | Iniziato | BofA Securities | Buy |
| 2024-02-27 | Iniziato | Morgan Stanley | Overweight |
Mostra tutto
Fractyl Health Inc Borsa (GUTS) Ultime notizie
Portfolio Shifts: Is Fractyl Health Inc undervalued by DCF analysis2026 Volatility Report & Low Risk Profit Maximizing Plans - baoquankhu1.vn
Fractyl Health (GUTS) stock jumps 21% after hours: Here's what you should know - MSN
Fractyl Health, Inc. (GUTS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
If You Invested $1,000 in Fractyl Health (GUTS) - Stock Titan
Pharma News: Is Fractyl Health Inc benefiting from interest rate changes2026 Big Picture & Growth Oriented Trading Recommendations - baoquankhu1.vn
Fractyl Health (GUTS) Projected to Post Quarterly Earnings on Monday - MarketBeat
Fractyl Health Earnings Call: Revita Nears Key Pivotal Test - The Globe and Mail
Scalable Biotech Manufacturing Unlocks a $14B Market - Benzinga
HC Wainwright Forecasts Fractyl Health Q1 Earnings - marketbeat.com
Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS), Merck & Company (MRK) and Abbott Laboratories (ABT) - The Globe and Mail
Fractyl Health, Inc. (NASDAQ:GUTS) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Market Recap: Is Fractyl Health Inc in a long term uptrend2026 Volume & Low Risk High Reward Ideas - baoquankhu1.vn
Short Interest in Fractyl Health, Inc. (NASDAQ:GUTS) Decreases By 55.7% - MarketBeat
Fractyl Health (NASDAQ:GUTS) Earns Buy Rating from Canaccord Genuity Group - MarketBeat
Analysts Offer Insights on Healthcare Companies: Fractyl Health, Inc. (GUTS) and Terns Pharmaceuticals (TERN) - The Globe and Mail
Fractyl Health FY2029 EPS Forecast Lifted by HC Wainwright - MarketBeat
Fractyl Health Faces Significant Compliance Risks Under Global Anti-Corruption and Sanctions Laws - TipRanks
BofA Securities Maintains Fractyl Health(GUTS.US) With Buy Rating - Moomoo
Fractyl Highlights Revita Progress and 2025 Financial Results - The Globe and Mail
Fractyl Health, Inc. Common Stock Q4 2025 Earnings Call Summary - Yahoo Finance
Fractyl Health (GUTS) Stock Jumps 21% After Hours: Here's What You Should Know - Benzinga
Fractyl Health Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Fractyl Health Inc (GUTS) Q4 2025 Earnings Call Highlights: Navigating Financial Challenges ... By GuruFocus - ca.investing.com
Fractyl Health outlines 2026 De Novo submission plans with pivotal Revita data expected in early Q4 - MSN
Disease-Modifying Therapies for Obesity and Type 2 Diabetes: Revita and Rejuva Pipeline Overview - Minichart
Fractyl Health Inc’s 2025 Q4 Call: CPT Code Timing, Regulatory Readiness, and Ablation Targets Don’t Align - Bitget
GUTS: Pivotal study enrollment complete; Revita advances toward key 2026 data and de novo submission - TradingView
Fractyl Health Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: Fractyl Health Q4 2025 sees cost cut, stock dips - Investing.com
Fractyl Health (NASDAQ:GUTS) Posts Narrower-Than-Expected Loss Ahead of Pivotal Trial Readout - ChartMill
FRACTYL HEALTH ($GUTS) Releases Q4 2025 Earnings - Quiver Quantitative
Fractyl Health (NASDAQ:GUTS) Releases Earnings Results, Misses Expectations By $0.13 EPS - MarketBeat
Fractyl Health Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates - The Manila Times
Fractyl Health 2025 10-K: $0M Revenue, Net Loss $140.954M - TradingView
Fractyl Health (NASDAQ: GUTS) outlines Revita device and Rejuva gene therapy plans - Stock Titan
Fractyl Health, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Fractyl Health (Nasdaq: GUTS) widens 2025 loss but advances pivotal Revita - Stock Titan
Fractyl Health, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Fractyl Health, Inc. (GUTS) loses 77.6% in 4 weeks, here's why a trend reversal may be around the corner - MSN
Fractyl Health (NASDAQ:GUTS) - intelligentinvestor.com.au
H.C. Wainwright Maintains a Buy Rating on Fractyl Health, Inc. (GUTS) with an $8 Price Target - Insider Monkey
Fractyl Health, Inc. (GUTS) moves to buy: Rationale behind the upgrade - MSN
Fractyl Health Receives Nasdaq Minimum Bid Price Notice - The Globe and Mail
Fractyl Health (Nasdaq: GUTS) faces Nasdaq minimum bid-price warning - Stock Titan
Fractyl Health to report fourth quarter and full year 2025 financial results and provide business updates on March 24, 2026 - MarketScreener
Fractyl Health To Report Fourth Quarter And Full Year 2025 Financial Results And Provide Business Updates On March 24, 2026 - TradingView
Fractyl Health to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Updates on March 24, 2026 - The Manila Times
Fractyl Health to Report Fourth Quarter and Full Year 2025 - globenewswire.com
Investment Report: What is the dividend yield of Fractyl Health Inc2026 Valuation Update & Growth Oriented Trade Recommendations - baoquankhu1.vn
Fractyl Health Inc Azioni (GUTS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):